The Combination of the Proteasome Inhibitor Bortezomib and the Bcl-2 Antisense Molecule Oblimersen Sensitizes Human B-Cell Lymphomas to Cyclophosphamide
Owen A. O’Connor(University of Virginia), Asher Chanan‐Khan(WinnMed)
Cited by 46
Related Papers
Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs
|Cancer Research|2008|222
Targeted inhibition of the deubiquitinating enzymes, <scp>USP</scp>14 and <scp>UCHL</scp>5, induces proteotoxic stress and apoptosis in <scp>W</scp>aldenström macroglobulinaemia tumour cells
|British Journal of Haematology|2015|61
<scp>AT</scp>‐101 downregulates <scp>BCL</scp>2 and <scp>MCL</scp>1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and <scp>W</scp>aldenström macroglobulinaemia
|British Journal of Haematology|2013|36
Preclinical Development of a Romidepsin Nanoparticle Demonstrates Superior Tolerability and Efficacy in Models of Human T-Cell Lymphoma and Large Granular Lymphocyte Leukemia
|bioRxiv (Cold Spring Harbor Laboratory)|2024|2